Geoffrey C Kabat1, Charles E Matthews1, Victor Kamensky1, Albert R Hollenbeck1, Thomas E Rohan1. 1. From the Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (GCK, VK, and TER); the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (CEM); and AARP, Washington, DC (ARH).
Abstract
BACKGROUND: Several health agencies have issued guidelines promoting behaviors to reduce chronic disease risk; however, little is known about the impact of such guidelines, particularly on cancer incidence. OBJECTIVE: The objective was to determine whether greater adherence to the American Cancer Society (ACS) cancer prevention guidelines is associated with a reduction in cancer incidence, cancer mortality, and total mortality. DESIGN: The NIH-AARP Diet and Health Study, a prospective cohort study of 566,401 adults aged 50-71 y at recruitment in 1995-1996, was followed for a median of 10.5 y for cancer incidence, 12.6 y for cancer mortality, and 13.6 y for total mortality. Participants who reported a history of cancer or who had missing data were excluded, yielding 476,396 subjects for analysis. We constructed a 5-level score measuring adherence to ACS guidelines, which included baseline body mass index, physical activity, alcohol intake, and several aspects of diet. Cox proportional hazards models were used to compute HRs and 95% CIs for the association of the adherence score with cancer incidence, cancer mortality, and total mortality. All analyses included fine adjustment for cigarette smoking. RESULTS: Among 476,396 participants, 73,784 incident first cancers, 16,193 cancer deaths, and 81,433 deaths from all causes were identified in the cohort. Adherence to ACS guidelines was associated with reduced risk of all cancers combined: HRs (95% CIs) for the highest compared with the lowest level of adherence were 0.90 (0.87, 0.93) in men and 0.81 (0.77, 0.84) in women. Fourteen of 25 specific cancer sites showed a reduction in risk associated with increased adherence. Adherence was also associated with reduced cancer mortality [HRs (95% CIs) were 0.75 (0.70, 0.80) in men and 0.76 (0.70, 0.83) in women] and reduced all-cause mortality [HRs (95% CIs) were 0.74 (0.72, 0.76) in men and 0.67 (0.65, 0.70) in women]. CONCLUSIONS: In both men and women, adherence to the ACS guidelines was associated with reductions in all-cancer incidence and the incidence of cancer at specific sites, as well as with reductions in cancer mortality and total mortality. These data suggest that, after accounting for cigarette smoking, adherence to a set of healthy behaviors may have considerable health benefits.
BACKGROUND: Several health agencies have issued guidelines promoting behaviors to reduce chronic disease risk; however, little is known about the impact of such guidelines, particularly on cancer incidence. OBJECTIVE: The objective was to determine whether greater adherence to the American Cancer Society (ACS) cancer prevention guidelines is associated with a reduction in cancer incidence, cancer mortality, and total mortality. DESIGN: The NIH-AARP Diet and Health Study, a prospective cohort study of 566,401 adults aged 50-71 y at recruitment in 1995-1996, was followed for a median of 10.5 y for cancer incidence, 12.6 y for cancer mortality, and 13.6 y for total mortality. Participants who reported a history of cancer or who had missing data were excluded, yielding 476,396 subjects for analysis. We constructed a 5-level score measuring adherence to ACS guidelines, which included baseline body mass index, physical activity, alcohol intake, and several aspects of diet. Cox proportional hazards models were used to compute HRs and 95% CIs for the association of the adherence score with cancer incidence, cancer mortality, and total mortality. All analyses included fine adjustment for cigarette smoking. RESULTS: Among 476,396 participants, 73,784 incident first cancers, 16,193 cancer deaths, and 81,433 deaths from all causes were identified in the cohort. Adherence to ACS guidelines was associated with reduced risk of all cancers combined: HRs (95% CIs) for the highest compared with the lowest level of adherence were 0.90 (0.87, 0.93) in men and 0.81 (0.77, 0.84) in women. Fourteen of 25 specific cancer sites showed a reduction in risk associated with increased adherence. Adherence was also associated with reduced cancer mortality [HRs (95% CIs) were 0.75 (0.70, 0.80) in men and 0.76 (0.70, 0.83) in women] and reduced all-cause mortality [HRs (95% CIs) were 0.74 (0.72, 0.76) in men and 0.67 (0.65, 0.70) in women]. CONCLUSIONS: In both men and women, adherence to the ACS guidelines was associated with reductions in all-cancer incidence and the incidence of cancer at specific sites, as well as with reductions in cancer mortality and total mortality. These data suggest that, after accounting for cigarette smoking, adherence to a set of healthy behaviors may have considerable health benefits.
Authors: A F Subar; D Midthune; M Kulldorff; C C Brown; F E Thompson; V Kipnis; A Schatzkin Journal: Am J Epidemiol Date: 2000-08-01 Impact factor: 4.897
Authors: Tim Byers; Marion Nestle; Anne McTiernan; Colleen Doyle; Alexis Currie-Williams; Ted Gansler; Michael Thun Journal: CA Cancer J Clin Date: 2002 Mar-Apr Impact factor: 508.702
Authors: Alice H Lichtenstein; Lawrence J Appel; Michael Brands; Mercedes Carnethon; Stephen Daniels; Harold A Franch; Barry Franklin; Penny Kris-Etherton; William S Harris; Barbara Howard; Njeri Karanja; Michael Lefevre; Lawrence Rudel; Frank Sacks; Linda Van Horn; Mary Winston; Judith Wylie-Rosett Journal: Circulation Date: 2006-06-19 Impact factor: 29.690
Authors: A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis Journal: Am J Epidemiol Date: 2001-12-15 Impact factor: 4.897
Authors: Majid Ezzati; Hilarie Martin; Suzanne Skjold; Stephen Vander Hoorn; Christopher J L Murray Journal: J R Soc Med Date: 2006-05 Impact factor: 5.344
Authors: Kim T B Knoops; Lisette C P G M de Groot; Daan Kromhout; Anne-Elisabeth Perrin; Olga Moreiras-Varela; Alessandro Menotti; Wija A van Staveren Journal: JAMA Date: 2004-09-22 Impact factor: 56.272
Authors: James R Cerhan; John D Potter; Julie M E Gilmore; Carol A Janney; Larry H Kushi; DeAnn Lazovich; Kristin E Anderson; Thomas A Sellers; Aaron R Folsom Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-07 Impact factor: 4.254
Authors: José Baselga; Nina Bhardwaj; Lewis C Cantley; Ronald DeMatteo; Raymond N DuBois; Margaret Foti; Susan M Gapstur; William C Hahn; Lee J Helman; Roy A Jensen; Electra D Paskett; Theodore S Lawrence; Stuart G Lutzker; Eva Szabo Journal: Clin Cancer Res Date: 2015-10-01 Impact factor: 12.531
Authors: Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan Journal: Am J Epidemiol Date: 2019-02-01 Impact factor: 4.897
Authors: Guillaume Onyeaghala; Anna K Lintelmann; Corrine E Joshu; Pamela L Lutsey; Aaron R Folsom; Kimberly Robien; Elizabeth A Platz; Anna E Prizment Journal: Cancer Date: 2019-12-24 Impact factor: 6.860
Authors: Lindsay N Kohler; David O Garcia; Robin B Harris; Eyal Oren; Denise J Roe; Elizabeth T Jacobs Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-06-23 Impact factor: 4.254
Authors: Adaline E Heitz; Richard N Baumgartner; Kathy B Baumgartner; Stephanie D Boone Journal: Breast Cancer Res Treat Date: 2017-08-31 Impact factor: 4.872
Authors: Sarah J O Nomura; Chiranjeev Dash; Lynn Rosenberg; Jeffrey Yu; Julie R Palmer; Lucile L Adams-Campbell Journal: Int J Cancer Date: 2016-09-19 Impact factor: 7.396